Table 2.
Distribution of Salmonella serovars among clinically significant organisms (CSO), Oriental Province, DRC, 2009–2014. Only first isolates were considered
| 2009–2010* | 2011 | 2012 | 2013 | 2014** | Total (% of all Salmonella isolates) | |
|---|---|---|---|---|---|---|
| (CSO = 92) | (CSO = 83) | (CSO = 78) | (CSO = 89) | (CSO = 54) | ||
| n (%) | n (%) | n (%) | n (%) | n (%) | ||
| Salmonella Typhi | 6 | 1 | 2 | 5 | 3 | 17 (13.1) |
| Salmonella Typhimurium | 9 | 6 | 13 | 14 | 12 | 54 (41.5) |
| Salmonella Enteritidis | 6 | 16 | 18 | 13 | 3 | 56 (43.1) |
| Other Salmonella serovars*** | 2 | 0 | 0 | 0 | 1 | 3 (2.3) |
| Total (% of CSO) | 23 (25.0) | 23 (27.7) | 33 (42.3) | 32 (35.9) | 19 (35.2) | 130 (100) |
* Data from 2009 and 2010 are grouped together as 2009 was considered as a pilot year (training and implementation)
** For 2014, data were completed till May 27th
*** Including Salmonella group B (one isolate) and Salmonella Kisangani (two isolates)